Pyrrolidine derivatives as antibacterial agents, current status and future prospects: a patent review
- PMID: 36366974
- DOI: 10.4155/ppa-2022-0015
Pyrrolidine derivatives as antibacterial agents, current status and future prospects: a patent review
Abstract
Bacterial infections are increasingly epitomizing major global health concerns, with rising death rates. Since the most complete assessment of the worldwide impact of antimicrobial resistance to date, with over 1.2 million people dead in 2019 as a direct result of antibiotic-resistant bacterial infections. The majority of antimicrobial drugs have been associated with a multitude of adverse effects including financial costs as well. Pyrrolidine derivatives have sparked the interest of researchers to create novel synthetic molecules with minimal side effect and drawbacks. To close the research gap, the current review discusses the synthetic compounds with active pyrrolidine scaffolds, critical findings and most crucially the structure-activity relationship that affects the activity of the ring over the last one and half decade.
Keywords: Gram-positive and Gram-negative bacteria; antibacterial; pyrrolidine; pyrrolidine derivatives; structure–activity relationship.
Similar articles
-
Synthesis and in-vitro activity of new 1beta-methylcarbapenem derivatives as antibacterial agents.Arch Pharm (Weinheim). 2008 Dec;341(12):780-6. doi: 10.1002/ardp.200800014. Arch Pharm (Weinheim). 2008. PMID: 19009543
-
Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.Arch Pharm (Weinheim). 2003 Nov;336(11):504-9. doi: 10.1002/ardp.200300756. Arch Pharm (Weinheim). 2003. PMID: 14639742
-
Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives.Arch Pharm (Weinheim). 2004 Jul;337(7):391-7. doi: 10.1002/ardp.200400867. Arch Pharm (Weinheim). 2004. PMID: 15237389
-
Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review).Eur J Med Chem. 2023 Jan 15;246:114954. doi: 10.1016/j.ejmech.2022.114954. Epub 2022 Nov 28. Eur J Med Chem. 2023. PMID: 36481599 Review.
-
Review on the Developments of Benzothiazole-containing Antimicrobial Agents.Curr Top Med Chem. 2022;22(32):2630-2659. doi: 10.2174/1568026623666221207161752. Curr Top Med Chem. 2022. PMID: 36503470 Review.
Cited by
-
Progress in the Stereoselective Synthesis Methods of Pyrrolidine-Containing Drugs and Their Precursors.Int J Mol Sci. 2024 Oct 17;25(20):11158. doi: 10.3390/ijms252011158. Int J Mol Sci. 2024. PMID: 39456938 Free PMC article. Review.
-
Juglans regia Linn.: A Natural Repository of Vital Phytochemical and Pharmacological Compounds.Life (Basel). 2023 Jan 30;13(2):380. doi: 10.3390/life13020380. Life (Basel). 2023. PMID: 36836737 Free PMC article. Review.
-
Pyrrolidine derivatives as α-amylase and α-glucosidase inhibitors: Design, synthesis, structure-activity relationship (SAR), docking studies and HSA binding.Heliyon. 2024 Oct 18;10(20):e39444. doi: 10.1016/j.heliyon.2024.e39444. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39502250 Free PMC article.
-
Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis.RSC Adv. 2025 Jun 3;15(23):18593-18647. doi: 10.1039/d5ra01077b. eCollection 2025 May 29. RSC Adv. 2025. PMID: 40463335 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous